The challenges to developing effective anti-biofilm therapies include targeting and delivery of therapeutic agents to the appropriate surface, the short duration that the agents remain in contact with the surface, release at the appropriate time, and clearance of the agents. These challenges are especially relevant in the dental field since therapeutic agents are not retained for sufficient duration due to rapid clearance.
This novel technology entails the use of pH-responsive nanoparticle carriers (NPC) that bind avidly to both the pellicle and exopolysaccharide-rich matrix (EPS) that builds up on teeth.
This approach allows for: